https://finance.yahoo.com/news/japan-says-drugmake
Post# of 144799
![](/assets/46931549/no_avatar_available_thumb.jpg)
Interesting statement
"A trial performed by the U.S. Institutes of Health (NIH) showed remdesivir drug cut hospital stays by 31% compared with a placebo treatment, although it did not significantly improve survival"
Did not improve survival, thats a shame. I wish it did improve survival but it doesn't, Leronlimab does significantly improve survival. Its a shame it hasn't yet been approved for comp use as of yet.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)